{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:12:10Z","timestamp":1787501530505,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.rcsop.2022.100174","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T23:34:01Z","timestamp":1661211241000},"page":"100174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Examining equity in a void of evidence - Pharmacist minor ailments services and the role of systematic reviews"],"prefix":"10.1016","volume":"7","author":[{"given":"Joanna","family":"Hikaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Haua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"612","key":"10.1016\/j.rcsop.2022.100174_bb0005","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.3399\/bjgp13X669194","article-title":"Are pharmacy-based minor ailment schemes a substitute for other service providers?","volume":"63","author":"Paudyal","year":"2013","journal-title":"Br J Gen Pract"},{"issue":"6","key":"10.1016\/j.rcsop.2022.100174_bb0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1715163515611144","article-title":"Canadian \u201cminor ailments\u201d programs","volume":"148","author":"Lee","year":"2015","journal-title":"Can Pharm J (Ott)"},{"key":"10.1016\/j.rcsop.2022.100174_bb0015","series-title":"Community Pharmacy Minor Ailments Service formulary","first-page":"60","author":"Formulary Subgroup of, NHS Highland Area Drug and Therapeutics Committee","year":"2017"},{"issue":"11","key":"10.1016\/j.rcsop.2022.100174_bb0020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.sapharm.2017.12.004","article-title":"A review of international pharmacy-based minor ailment services and proposed service design model","volume":"14","author":"Aly","year":"2018","journal-title":"Res. Social Adm. Pharm."},{"issue":"9","key":"10.1016\/j.rcsop.2022.100174_bb0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/IJGM.S99540","article-title":"Pharmacist-led minor ailment programs: a Canadian perspective","volume":"10","author":"Taylor","year":"2016","journal-title":"Int J Gen Med"},{"issue":"2","key":"10.1016\/j.rcsop.2022.100174_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/ijpp.12128","article-title":"Evaluating pharmacist prescribing for minor ailments","volume":"23","author":"Mansell","year":"2015","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"10.1016\/j.rcsop.2022.100174_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12962-017-0066-7","article-title":"Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan","volume":"15","author":"Rafferty","year":"2017","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.rcsop.2022.100174_bb0040","author":"Research Power Inc"},{"issue":"96","key":"10.1016\/j.rcsop.2022.100174_bb0045","first-page":"1","article-title":"Pharmacist prescribing for minor ailment service development: the experience in Ontario","volume":"9","author":"Nakhla","year":"2021","journal-title":"Pharmacy."},{"key":"10.1016\/j.rcsop.2022.100174_bb0050","author":"Ministry of Health"},{"issue":"1","key":"10.1016\/j.rcsop.2022.100174_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12913-021-06076-1","article-title":"Co-design and feasibility of a pharmacist-led minor ailment service","volume":"21","author":"Dineen-Griffin","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"1485","key":"10.1016\/j.rcsop.2022.100174_bb0060","article-title":"Te Wero tonu\u2014the challenge continues: M\u0101ori access to medicines 2006\/07\u20132012\/13 update","volume":"131","author":"Metcalfe","year":"2018","journal-title":"NZ Med J"},{"issue":"3","key":"10.1016\/j.rcsop.2022.100174_bb0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40266-020-00828-0","article-title":"Ethnic variations in the quality use of medicines in older adults: M\u0101ori and non-M\u0101ori in Aotearoa New Zealand","volume":"38","author":"Hikaka","year":"2021","journal-title":"Drugs Aging"},{"key":"10.1016\/j.rcsop.2022.100174_bb0070","series-title":"Wai 2575 M\u0101ori Health Trends Report.","author":"Ministry of Health","year":"2019"},{"issue":"8","key":"10.1016\/j.rcsop.2022.100174_bb0075","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/pds.5028","article-title":"Ethnic inequality in non-steroidal anti-inflammatory drug-associated harm in New Zealand: a national population-based cohort study","volume":"29","author":"Tomlin","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.rcsop.2022.100174_bb0080","series-title":"Pharmacy Services Expert Advisory Group meeting minutes","author":"Technical Advisory Services Ltd","year":"2019"},{"issue":"5","key":"10.1016\/j.rcsop.2022.100174_bb0085","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2710.2004.00591.x","article-title":"Community pharmacy treatment of minor ailments in refugees","volume":"29","author":"Parmentier","year":"2004","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"10.1016\/j.rcsop.2022.100174_bb0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.japh.2018.08.008","article-title":"Pharmacist, physician, and patient opinions of pharmacist-treated minor ailments and conditions","volume":"58","author":"McKeirnan","year":"2003","journal-title":"J Am Pharm Assoc"},{"issue":"10","key":"10.1016\/j.rcsop.2022.100174_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205087","article-title":"Methodological considerations in clinical outcomes assessment of pharmacy-based minor ailments management: a systematic review","volume":"13","author":"Paudyal","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rcsop.2022.100174_bb0100","series-title":"PSNC Briefing 044\/17: Analysis of Minor Ailment Services Data","author":"Pharmaceutical Services","year":"2017"},{"issue":"6","key":"10.1016\/j.rcsop.2022.100174_bb0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jclinepi.2007.01.005","article-title":"Empty systematic reviews: hidden perils and lessons learned","volume":"60","author":"Lang","year":"2007","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.rcsop.2022.100174_bb0110","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.sapharm.2020.05.007","article-title":"What free services do pharmacists offer? Investigating the provision of unfunded pharmacy services in community pharmacies","volume":"17","author":"Abdul Aziz","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2022.100174_bb0115","author":"Ministry of Health"},{"issue":"10","key":"10.1016\/j.rcsop.2022.100174_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001333","article-title":"PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity","volume":"9","author":"Welch","year":"2012","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.rcsop.2022.100174_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/2046-4053-2-43","article-title":"Health equity: evidence synthesis and knowledge translation methods","volume":"2","author":"Welch","year":"2013","journal-title":"Syst Rev."},{"issue":"12","key":"10.1016\/j.rcsop.2022.100174_bb0130","article-title":"Challenges and strategies for promoting health equity in virtual care: protocol for a scoping review of reviews","volume":"9","author":"Fujioka","year":"2020","journal-title":"JMIR ResProtoc"},{"issue":"1","key":"10.1016\/j.rcsop.2022.100174_bb0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13643-019-1009-5","article-title":"Searching for health equity: validation of a search filter for ethnic and socioeconomic inequalities in transport","volume":"8","author":"Hosking","year":"2019","journal-title":"Syst Rev."},{"issue":"1","key":"10.1016\/j.rcsop.2022.100174_bb0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13643-015-0125-0","article-title":"Applying systematic review search methods to the grey literature: a case study examining guidelines for school-based breakfast programs in Canada","volume":"4","author":"Godin","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.rcsop.2022.100174_bb0145","author":"Cochrane Effective Practice and Organisation of Care (EPOC)"},{"key":"10.1016\/j.rcsop.2022.100174_bb0150","author":"Cochrane Effective Practice and Organisation of Care (EPOC)"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276622000737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276622000737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:28:57Z","timestamp":1757406537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276622000737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"alternative-id":["S2667276622000737"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2022.100174","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining equity in a void of evidence - Pharmacist minor ailments services and the role of systematic reviews","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2022.100174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100174"}}